Arete Wealth Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Arete Wealth Advisors’s Portfolio BTAL Stock Details BTAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$782K	Buy	65,220 +450	+0.7%	+$5.42K	0.05%	264
2026 Q2	$722K	Buy	64,770 +13,005	+25%	+$158K	0.05%	257
2026 Q1	$723K	Buy	51,765 +13,711	+36%	+$192K	0.05%	244
2025 Q4	$548K	Buy	38,054 +1,801	+5%	+$27.1K	0.04%	293
2025 Q3	$577K	Buy	+36,253	New	+$597K	0.04%	278
2019 Q2	–	Sell	-471,136	Closed	-$10.2M	–	394
2019 Q1	$10.2M	Buy	471,136 +442,935	+1,571%	+$9.43M	2.12%	5
2018 Q4	$624K	Buy	+28,201	New	+$600K	0.15%	167

Other funds holding BTAL

Carrera Capital Advisors Troy, Michigan $705M AUM 12.86% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.18B AUM 13.12% 1-Year Est. Return

Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return

IFG Advisory Atlanta, Georgia $3.01B AUM 18.54% 1-Year Est. Return

WealthPlan Investment Management Omaha, Nebraska $2.07B AUM 21.2% 1-Year Est. Return

PMV Capital Advisers Dallas, Texas $80M AUM 20.89% 1-Year Est. Return

CFA

Collaborative Fund Advisors Reno, Nevada $186M AUM

Good Steward Wealth Advisors Clarksville, Tennessee $167M AUM 10.63% 1-Year Est. Return

Avestar Capital New York $1.27B AUM 25.49% 1-Year Est. Return

Arete Wealth Advisors's BTAL Position: Q3 2026 in Review

Arete Wealth Advisors increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 0.69% in Q3 2026, buying an estimated $5.42K and bringing the position to 65,220 shares worth $782K. The position accounts for 0.05% of the portfolio, ranked #264.

Arete Wealth Advisors first reported a position in BTAL in Q4 2018 and has held it in 7 quarters since. The position peaked at $10.2M in Q1 2019. 49 funds tracked by Wall St. Rank hold BTAL as of Q3 2026.

Arete Wealth Advisors held 65,220 shares of AGF US Market Neutral Anti-Beta Fund worth $782K as of Q3 2026.
Arete Wealth Advisors bought 450 AGF US Market Neutral Anti-Beta Fund shares in Q3 2026, an estimated $5.42K.
AGF US Market Neutral Anti-Beta Fund made up 0.05% of Arete Wealth Advisors's portfolio in Q3 2026, its #264 holding.
Arete Wealth Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2018 and has held it in 7 quarters since.
Arete Wealth Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $10.2M in Q1 2019.
49 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2026.

Based on Arete Wealth Advisors's 13F filing for Q3 2026, filed 9 Nov 2026.